Sort by
Refine Your Search
-
Employer
- University Medical Center Utrecht (UMC Utrecht)
- University of Groningen
- ; University of Birmingham
- AcademicTransfer
- Eindhoven University of Technology
- Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
- University Medical Centre Groningen (UMCG)
- Vrije Universiteit Amsterdam (VU)
- Wageningen University & Research
- Wageningen University and Research Center
-
Field
-
another to induce a series of reactions that help to fight infection. Although crucial for local clearance of infections, erroneous activation of complement on the body's own cells is the root cause of many
-
this pressing issue by developing novel carriers and innovative infection models (both 2D and 3D) to eradicate these intracellular pathogens and unveil underlying mechanisms driving resistance. This project
-
antibiotics in treating multi-resistant bacterial infections. Bacteria evolved defense systems to overcome bacteriophage killing. This limits phage host range and complicates routine therapeutic application
-
programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Phage therapy is a promising alternative for antibiotics in treating multi-resistant bacterial infections
-
nutritional intake, pain, blood stream infections, treatment delays and decreased quality of life. Unfortunately, there are no interventions that prevent or shorten the course of GI mucositis. In our research
-
involving experimental and theoretical biologists, funded by the Netherlands Organisation for Scientific Research (NWO). Antibiotic-resistant bacterial infections pose a growing global health problem
-
Scientific Research (NWO). Antibiotic-resistant bacterial infections pose a growing global health problem. To understand and possibly predict evolutionary trajectories towards antibiotic resistance, we need
-
what would happen if circumstances change. As a postdoctoral researcher you will focus on building individual-based transmission models for sexually transmitted infections (STI) and measles. For the STI
-
opportunities for precise targeting of e.g. tumors, and bacterial infections. High precision cancer chemotherapy, fighting bacterial resistance or infectious biofilms are among the prospects for future clinical
-
. The technological challenge is to accurate collect and size-separate droplets in the air, without affecting virus infectivity, while achieving high throughput. The device will be designed through a combination of